跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Reverse - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Reverse
Approved
STANDARD
Reverse
Aspiro Pharma Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1cad2de68487d08e
Company
Aspiro Pharma Limited
Type
Standard
Approval Details
Approval Id
1cad2de68487d08e
Drug Approval Philippines Name
Reverse
Product Name
Reverse
Registration Number
DRP-13801-01
Brand Name
Reverse
Generic Name
Sugammadex (as sodium)
Dosage Form
Solution for Injection (IV)
Dosage Strength
100 mg/mL
Manufacturer
Aspiro Pharma Limited
Importer
Camber Pharmaceuticals, Inc
Distributor
Biocare Lifesciences, Inc.
Company Detail Path
/organization/aspiro-pharma-limited
Importer Detail Path
/organization/camber-pharmaceuticals-inc
Issuance Date
31 July 2023
Expiry Date
27 April 2028
Pharmacologic Category
Antidote
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1cad2de68487d08e
Type
Standard
Back to Philippines FDA Approvals